Listen Now

Topics Covered

  • What’s New in the Treatment of WM
  • Symptoms & Signs
  • Front Line Treatment of WM
  • Treatment for Relapsed/Refractory WM
  • Standard of Care & New Treatment Approaches
  • Clinical Trial Updates
  • Managing Symptoms & Side Effects, including Controlling Complications
  • Managing Peripheral Neuropathy
  • Key Questions to Ask Your Health Care Team, including Treatment Follow-Up Care
  • Quality-of-Life Concerns
  • Mapping the Future of WM
  • Questions for Our Panel of Experts

Our Panel of Experts

Steven Treon, MD, PhD

Director, Bing Center for Waldenstrom’s Macroglobulinemia, Professor, Harvard Medical School, Dana Farber Cancer Institute

Christian Buske, MD

Medical Director, Comprehensive Cancer Centre and Institute of Experimental Cancer Research, University of Ulm, Attending Physician & Professor of Medicine, Medical Department for Internal Medicine III, Hematology/Oncology, University Hospital, Ulm, Germany

Carl Harrington

Chair, IWMF Board of Trustees, The International Waldenstrom’s Macroglobulinemia Foundation

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(161 KB)

Workshop Date

This workshop was originally recorded on March 19, 2020.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.